Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872701 · ClinicalTrials.gov registry record · Phase 2
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
A Phase 2 study, sponsored by On Target Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT02872701: Completed Phase 2 study, sponsored by On Target Laboratories.
NCT02872701 is a Phase 2 study that has completed, run by On Target Laboratories. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02872701, a Phase 2 study, has completed, sponsored by On Target Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a phase 2, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/positron emission tomography imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary nodules within the operating theater, and to assess the safety and tolerability of single intravenous doses of OTL38.
Interventions
- DRUG OTL38 for Injection
- DEVICE Near infrared camera imaging system
- PROCEDURE Endoscopic or Thoracic Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-04 |
| Est. Completion | 2018-11-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02872701
The ClinicalTrials.gov registry entry for NCT02872701 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is On Target Laboratories, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which OTL38 for Injection is the first listed.
NCT02872701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02872701 about?
NCT02872701 is a clinical study titled "OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules". This is a phase 2, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/positron emission tomography imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared I...
What is the current status of trial NCT02872701?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2017-05-04. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT02872701?
The interventions under investigation include: OTL38 for Injection (DRUG), Near infrared camera imaging system (DEVICE), Endoscopic or Thoracic Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02872701?
This trial is sponsored by On Target Laboratories, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.